The Group Elite team has a special connection with a young girl who has directly benefited from the Retinoblastoma Program at The Hospital for Sick Children (SickKids).
World renowned innovative techniques and the dedicated team of experts at SickKids are her best hope at retaining the ability to experience vision.
Retinoblastoma is a rare but devasting form of childhood cancer affecting the retina at the back of eye. Treatments are designed to kill the tumour cells and to preserve vision as much as possible. Group Elite is supporting the STEP-RB clinical trial led by Dr. Brenda Gallie, Ophthalmologist & Vision Science Department at SickKids.
Positive results from the study could be a step toward new treatment options for patients with retinoblastoma.
SickKids, affiliated with the University of Toronto, is Canada's most research-intensive hospital and the largest centre dedicated to improving children's health in the country
SickKids plays a crucial role as an international referral centre for treating retinoblastoma patients, who require the care of a multidisciplinary team that includes pediatric oncologists and ophthalmology specialists.
Click the Canadian flag to support SickKids directly from the Group Elite giving portal.
Click the American flag to partner with Network for Good and donate to SickKids today. Please enter Retinoblastoma Clinical Trial at SickKids from Group Elite in the Designation box.